中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2012年
3期
237-242
,共6页
于胜波%崔红营%秦牧%刘韬%孔斌%赵庆彦%黄鹤%黄从新
于勝波%崔紅營%秦牧%劉韜%孔斌%趙慶彥%黃鶴%黃從新
우성파%최홍영%진목%류도%공빈%조경언%황학%황종신
心力衰竭,充血性%红细胞%预后
心力衰竭,充血性%紅細胞%預後
심력쇠갈,충혈성%홍세포%예후
Heart failure,congestive%Erythrocytes%Prognosis
目的 探讨红细胞分布宽度(RDW)对慢性收缩性心力衰竭(心衰)患者预后的预测价值及相关因素分析.方法 回顾性调查和分析湖北地区8地市12家三级甲等医院2000年至2010年心衰住院患者临床资料,所有患者经电话随访.根据RDW将患者分为≤l3.2%(3981例)、13.3% ~ 14.1%(3996例)、14.2% ~ 14.8%(4319例)和≥14.9%(4385例)组,根据平均红细胞体积(MCV)将RDW> 16%患者分为MCV减低组(MCV< 82 fl,420例)、MCV升高组(MCV >92 fl,646例)和MCV正常组(MCV≥82 fl、≤92 fl,632例).根据患者是否死亡,分为死亡组和存活组.以单因素和多因素Cox生存分析评价RDW预测总体和不同病因心衰患者预后价值、不同RDW组和MCV组总死亡风险.单因素和多因素回归分析评价RDW与其他指标相关性.结果 (1)共16 681例患者纳入研究.以RDW≤13.2%组做参照,RDW13.3% ~14.1%、14.2% ~ 14.8%和≥14.9%组总死亡风险分别为0.892(95% CI0.818 ~0.973,P=0.01)、0.859(95% CI 0.793 ~0.931,P<0.01)和1.034(95% CI 0.961 ~1.111,P=0.373).(2)在RDW >16%患者中,以风湿性瓣膜病做参考,缺血性心肌病、扩张型心肌病和高血压心脏病总死亡风险分别为1.437(95% CI 1.141~1.810,P<0.01)、1.651(95% CI 1.276 ~2.138,P<0.01)和1.276(95%CI 1.004~1.621,P<0.01). (3)在RDW> 16%患者中,以MCV正常组做参照,MCV升高组和MCV减低组总死亡风险分别为1.351(95%CI 1.063 ~1.718,P<0.01)和1.316(95% CI 1.034 ~1.675,P<0.01).(4) RDW相关因素在不同病因中存在差异.结论 慢性收缩性心衰患者总病死率与RDW间存在J型分布,RDW升高伴MCV增高或减低均增加总死亡风险,评价RDW的预后价值需考虑病因因素.
目的 探討紅細胞分佈寬度(RDW)對慢性收縮性心力衰竭(心衰)患者預後的預測價值及相關因素分析.方法 迴顧性調查和分析湖北地區8地市12傢三級甲等醫院2000年至2010年心衰住院患者臨床資料,所有患者經電話隨訪.根據RDW將患者分為≤l3.2%(3981例)、13.3% ~ 14.1%(3996例)、14.2% ~ 14.8%(4319例)和≥14.9%(4385例)組,根據平均紅細胞體積(MCV)將RDW> 16%患者分為MCV減低組(MCV< 82 fl,420例)、MCV升高組(MCV >92 fl,646例)和MCV正常組(MCV≥82 fl、≤92 fl,632例).根據患者是否死亡,分為死亡組和存活組.以單因素和多因素Cox生存分析評價RDW預測總體和不同病因心衰患者預後價值、不同RDW組和MCV組總死亡風險.單因素和多因素迴歸分析評價RDW與其他指標相關性.結果 (1)共16 681例患者納入研究.以RDW≤13.2%組做參照,RDW13.3% ~14.1%、14.2% ~ 14.8%和≥14.9%組總死亡風險分彆為0.892(95% CI0.818 ~0.973,P=0.01)、0.859(95% CI 0.793 ~0.931,P<0.01)和1.034(95% CI 0.961 ~1.111,P=0.373).(2)在RDW >16%患者中,以風濕性瓣膜病做參攷,缺血性心肌病、擴張型心肌病和高血壓心髒病總死亡風險分彆為1.437(95% CI 1.141~1.810,P<0.01)、1.651(95% CI 1.276 ~2.138,P<0.01)和1.276(95%CI 1.004~1.621,P<0.01). (3)在RDW> 16%患者中,以MCV正常組做參照,MCV升高組和MCV減低組總死亡風險分彆為1.351(95%CI 1.063 ~1.718,P<0.01)和1.316(95% CI 1.034 ~1.675,P<0.01).(4) RDW相關因素在不同病因中存在差異.結論 慢性收縮性心衰患者總病死率與RDW間存在J型分佈,RDW升高伴MCV增高或減低均增加總死亡風險,評價RDW的預後價值需攷慮病因因素.
목적 탐토홍세포분포관도(RDW)대만성수축성심력쇠갈(심쇠)환자예후적예측개치급상관인소분석.방법 회고성조사화분석호북지구8지시12가삼급갑등의원2000년지2010년심쇠주원환자림상자료,소유환자경전화수방.근거RDW장환자분위≤l3.2%(3981례)、13.3% ~ 14.1%(3996례)、14.2% ~ 14.8%(4319례)화≥14.9%(4385례)조,근거평균홍세포체적(MCV)장RDW> 16%환자분위MCV감저조(MCV< 82 fl,420례)、MCV승고조(MCV >92 fl,646례)화MCV정상조(MCV≥82 fl、≤92 fl,632례).근거환자시부사망,분위사망조화존활조.이단인소화다인소Cox생존분석평개RDW예측총체화불동병인심쇠환자예후개치、불동RDW조화MCV조총사망풍험.단인소화다인소회귀분석평개RDW여기타지표상관성.결과 (1)공16 681례환자납입연구.이RDW≤13.2%조주삼조,RDW13.3% ~14.1%、14.2% ~ 14.8%화≥14.9%조총사망풍험분별위0.892(95% CI0.818 ~0.973,P=0.01)、0.859(95% CI 0.793 ~0.931,P<0.01)화1.034(95% CI 0.961 ~1.111,P=0.373).(2)재RDW >16%환자중,이풍습성판막병주삼고,결혈성심기병、확장형심기병화고혈압심장병총사망풍험분별위1.437(95% CI 1.141~1.810,P<0.01)、1.651(95% CI 1.276 ~2.138,P<0.01)화1.276(95%CI 1.004~1.621,P<0.01). (3)재RDW> 16%환자중,이MCV정상조주삼조,MCV승고조화MCV감저조총사망풍험분별위1.351(95%CI 1.063 ~1.718,P<0.01)화1.316(95% CI 1.034 ~1.675,P<0.01).(4) RDW상관인소재불동병인중존재차이.결론 만성수축성심쇠환자총병사솔여RDW간존재J형분포,RDW승고반MCV증고혹감저균증가총사망풍험,평개RDW적예후개치수고필병인인소.
Objective To determinate the prognostic value of red cell distribution width (RDW) and the relationships between RDW and clinical characteristics in patients with chronic heart failure (CHF).Methods A total of 16 681 in-hospital patients with chronic systolic HF and LVEF <50% from 12 hospitals in Hubei province,China were enrolled.All patients were followed up with telephone call.Patients were divided into RDW ≤ 13.2% (n =3981 ),13.3% - 14.1% (n =3996),14.2% - 14.8% ( n =4319) and ≥14.9% (n =4385 )groups.Multivariate Cox regression analysis was performed to determine whether RDW is an independent risk factor of all-cause mortality in overall patients,patients with various etiologies.Multivariate Cox proportional hazard analysis was performed to determine the risk of all-cause mortality among various RDW groups.Results ( 1 ) Compared with RDW ≤ 13.2% group,adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of all-cause mortality for RDW 13.3% -14.1%,14.2% -14.8% and ≥ 14.9% were 0.892 (95 % CI 0.818-0.973,P =0.01 ),0.859 (95 % CI 0.793 -0.931,P <0.01) and 1.034 (95% CI 0.961 - 1.111,P =0.373) respectively. (2) Compared with MCV normal group,the adjusted HRs of MCV elevation and MCV decline groups were 1.351 (95% CI 1.063 - 1.718,P <0.01 ) and 1.316 (95% CI 1.034 - 1.675,P < 0.01 ),respectively.(3) Compared to patients with rheumatic heart diseases,the adjusted HR for all-cause mortality in patients with coronary heart disease,dilated cardiomyopathy and hypertensive heart disease with RDW > 16% were 1.437 (95% CI 1.141 -1.810,P<0.01),1.651 (95% CI 1.276 -2.138,P<0.01) and 1.276 (95% CI 1.004- 1.621,P < 0.01 ),respectively.(4) The RDW is independently correlated with BMI ( r =- 0.345,P < 0.01 ),diastolic blood pressure( r =- 0.321,P < 0.01 ),albumin ( r =- 0.411,P < 0.01 ),blood urine nitrogen ( r =0.476,P < 0.01 ),right ventricular end-diastolic diameter( r =0.383,P < 0.01 ),LVEF ( r =- 0.463,P <0.01 ) and heart rate( r =0.379,P <0.01 ).Conclusions There is a J shape relationship between allcause mortality and RDW.The elevation or decline of MCV with increased RDW is hnked with increased allcause mortality in CHF patients.